Anita Mazloom

5PUBLICATIONS
16CO-AUTHORS
Gene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

|May 26, 2026
High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.

|May 26, 2026
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients.

|Mar 27, 2026
Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.

Sruthi P Ramanan, Oyepeju F Abioye, Shebli Atrash

|Nov 13, 2025
Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals.

Jordan Snyder, Shebli Atrash, Barry Paul

Pageof 1

Frequent Collaborators

5 joint publications

Shebli Atrash

5 joint publications

Omar Alkharabsheh

5 joint publications

Zahra Mahmoudjafari

5 joint publications

Al-Ola Abdallah